Profound Medical Corp. logo
Profound Medical Corp. PROF
$ 6.88 1.32%
report update icon

Quarterly report 2026-Q2
added 08-06-2026

Profound Medical Corp. Financial Statements 2025-2011 | PROF

Annual Financial Statements Profound Medical Corp.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

166 M 185 M 173 M 183 M 230 M 228 M 121 M 88.1 M - - - - - - -

Shares

30.2 M 24.8 M 21.2 M 20.8 M 20.5 M 11.1 M 11.1 M 10 M - - - - - - -

Historical Prices

5.49 7.45 8.18 8.78 11.2 20.6 10.9 - - - - - - - -

Net Income

-42.6 M -27.8 M -28.3 M -28.7 M -30.7 M -21.6 M -20.2 M -20.8 M -18.8 M -12.1 M -11.8 M -8.2 M - - -

Revenue

16.1 M 10.7 M 7.2 M 6.68 M 6.87 M 7.3 M 4.17 M 2.6 M 4.9 M - - - - - -

Cost of Revenue

4.7 M 3.64 M 2.89 M 3.66 M 3.92 M 3.83 M 1.78 M - - - - - - - -

Gross Profit

11.4 M 7.04 M 4.31 M 3.02 M 2.95 M 3.47 M - - 1.87 M - - - - - -

Operating Income

-41.3 M -33.1 M -28.7 M -32.1 M -30.3 M -18.9 M -14.9 M - - - - - - - -

Interest Expense

- - 146 K 290 K 448 K - - - - - - - - - -

EBITDA

-40.9 M -32.4 M -27.9 M -32.1 M -30.3 M -18.9 M -14.9 M - -17.2 M -11.4 M -9.39 M -6.18 M - - -

Operating Expenses

52.6 M 40.1 M 33 M 35.1 M 33.2 M 22.3 M 17.3 M 21 M 19.5 M - - - - - -

General and Administrative Expenses

32.1 M 23.1 M 9.17 M 9.46 M 10.3 M 7.56 M 7.68 M 6.66 M 5.94 M 4.2 M 4.39 M 1.95 M - - -

All numbers in USD currency

Quarterly Income Statement Profound Medical Corp.

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2023-Q4 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

36.4 M 36.3 M 30.1 M 30.1 M 30 M 21.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-9.54 M -7.05 M -7.98 M -15.7 M -10.7 M -28.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

2.48 M 5.34 M 5.29 M 2.21 M 2.62 M 7.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

536 K 1.5 M 1.36 M 593 K 768 K 2.82 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

1.95 M 3.83 M 3.93 M 1.62 M 1.85 M 4.38 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-11.1 M -8.02 M -8.91 M -13.8 M -11.2 M -28.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - 146 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-10.9 M -7.93 M -8.82 M -13.7 M -11 M -28.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

13 M 11.9 M 12.8 M 15.4 M 13 M 33 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

7.36 M 6.59 M 7.43 M 9.33 M 8.21 M 9.17 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Profound Medical Corp. PROF
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Profound Medical Corp. plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Abbott Laboratories Abbott Laboratories
ABT
$ 105.33 0.03 % $ 183 B usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 62.37 0.06 % $ 1.83 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.69 1.21 % $ 11.7 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 84.12 0.84 % $ 1.07 B usaUSA
LENSAR LENSAR
LNSR
$ 8.54 1.11 % $ 102 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 2.16 1.77 % $ 87.9 M usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 91.79 1.15 % $ 118 B usaUSA
MiMedx Group MiMedx Group
MDXG
$ 4.53 3.16 % $ 670 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Myomo Myomo
MYO
$ 1.35 2.86 % $ 56.5 M usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
$ 0.86 3.64 % $ 55.7 M israelIsrael
InspireMD InspireMD
NSPR
$ 0.83 1.09 % $ 53.4 M israelIsrael
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
- 10.28 % $ 55.5 M israelIsrael
Inari Medical Inari Medical
NARI
- - $ 4.23 B usaUSA
Nemaura Medical Nemaura Medical
NMRD
- -17.8 % $ 2.74 M britainBritain
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
SmileDirectClub SmileDirectClub
SDC
- -53.45 % $ 9.71 M usaUSA
Sientra Sientra
SIEN
- -16.59 % $ 10.3 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
- - $ 1.07 B usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
- -32.98 % $ 1.68 M usaUSA
ShockWave Medical ShockWave Medical
SWAV
- - $ 12.3 B usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
- -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
- 3.55 % $ 7.96 M usaUSA
Viveve Medical Viveve Medical
VIVE
- -15.35 % $ 1.71 M usaUSA
ViewRay ViewRay
VRAY
- 1.54 % $ 468 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 9.0 0.11 % $ 356 M curacaoCuracao
Outset Medical Outset Medical
OM
$ 3.48 0.7 % $ 52.9 K usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 1.82 1.31 % $ 1.23 M usaUSA
Align Technology Align Technology
ALGN
$ 154.0 0.03 % $ 11.2 B usaUSA
Delcath Systems Delcath Systems
DCTH
$ 16.1 1.1 % $ 577 M usaUSA
PAVmed PAVmed
PAVM
$ 4.9 3.73 % $ 3.29 M usaUSA
Inogen Inogen
INGN
$ 5.26 0.18 % $ 140 M usaUSA
InMode Ltd. InMode Ltd.
INMD
$ 14.79 0.47 % $ 956 M israelIsrael
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 21.84 1.17 % $ 512 M usaUSA
Penumbra Penumbra
PEN
$ 320.07 0.32 % $ 12.5 B usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 139.77 1.65 % $ 9.83 B usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
$ 2.71 0.56 % $ 116 M usaUSA
AVITA Medical AVITA Medical
RCEL
$ 10.58 2.38 % $ 295 M australiaAustralia
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 126.39 0.8 % $ 4.39 B usaUSA
Sintx Technologies Sintx Technologies
SINT
$ 1.67 2.45 % $ 4.63 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 27.84 0.16 % $ 24.1 B britainBritain
Sensus Healthcare Sensus Healthcare
SRTS
$ 3.2 0.31 % $ 52.2 M usaUSA
Stryker Corporation Stryker Corporation
SYK
$ 276.24 0.68 % $ 106 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 21.54 0.09 % $ 493 M usaUSA